Cordoba

我们是谁

• 1 月 17, 2024

  ZN-c3 in Adult Participants With BRAF mutant Metastatic Colorectal Cancer

• 1 月 9, 2024

  Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)

• 4 月 5, 2022

  BMS-986288单独或与Nivolumab联合治疗晚期实体瘤的免疫疗法研究